Age (years) | |
Mean (SD) | 56.6 (9.2) |
Range | 29–87 |
Sex | |
Female | 64.4 (67) |
Male | 35.6 (37) |
BMI, mean (SD) | 35.7 (7.8) |
Hispanic ethnicity (n = 93) | 26.9 (25) |
Education level (n = 103) | |
Less than high school diploma | 17.5 (18) |
High school diploma | 16.5 (17) |
Some college | 34.0 (35) |
College degree | 19.4 (20) |
Some graduate school or degree | 12.6 (13) |
Yearly family income (n = 98) | |
<$10,000 | 18.4 (18) |
$10,000–14,999 | 14.3 (14) |
$15,000–24,999 | 19.4 (19) |
$25,000–49,999 | 28.6 (28) |
$50,000–99,999 | 18.4 (18) |
$100,000–149,999 | 1.0 (1) |
Years since diagnosis (n = 102), mean (SD) | 12.5 (9.3) |
Baseline A1C, mean (SD) | |
Percentage | 7.8 (1.6) |
Millimoles per mole | 61.2 (17.1) |
Prescribed insulin | 38.5 (40) |
MDD diagnosis based on the MINI (n = 103) | |
Current | 7.7 (8) |
Past | 12.5 (13) |
Total diabetes distress, mean (SD) | 2.3 (1.2) |
Clinically significant diabetes distress | 46.2 (48) |
Emotional burden | 2.5 (1.5) |
Total PHQ-9 score, mean (SD) | 5.9 (5.6) |
Screened positive | 21.2 (22) |
Somatic symptoms | 3.4 (2.9) |
Cognitive-affective symptoms | 2.5 (3.1) |
Total MADRS score, mean (SD) | 10.1 (9.0) |
Somatic symptoms | 3.5 (3.5) |
Cognitive-affective symptoms | 6.6 (6.3) |
Self-reported medication adherence | |
Percentage-based ratings, mean (SD) | 83.7 (21.9) |
Categorical ratings | |
Very poor | 0 (0) |
Poor | 6.7 (7) |
Fair | 8.7 (9) |
Good | 19.2 (20) |
Very good | 27.9 (29) |
Excellent | 37.5 (39) |
Age (years) | |
Mean (SD) | 56.6 (9.2) |
Range | 29–87 |
Sex | |
Female | 64.4 (67) |
Male | 35.6 (37) |
BMI, mean (SD) | 35.7 (7.8) |
Hispanic ethnicity (n = 93) | 26.9 (25) |
Education level (n = 103) | |
Less than high school diploma | 17.5 (18) |
High school diploma | 16.5 (17) |
Some college | 34.0 (35) |
College degree | 19.4 (20) |
Some graduate school or degree | 12.6 (13) |
Yearly family income (n = 98) | |
<$10,000 | 18.4 (18) |
$10,000–14,999 | 14.3 (14) |
$15,000–24,999 | 19.4 (19) |
$25,000–49,999 | 28.6 (28) |
$50,000–99,999 | 18.4 (18) |
$100,000–149,999 | 1.0 (1) |
Years since diagnosis (n = 102), mean (SD) | 12.5 (9.3) |
Baseline A1C, mean (SD) | |
Percentage | 7.8 (1.6) |
Millimoles per mole | 61.2 (17.1) |
Prescribed insulin | 38.5 (40) |
MDD diagnosis based on the MINI (n = 103) | |
Current | 7.7 (8) |
Past | 12.5 (13) |
Total diabetes distress, mean (SD) | 2.3 (1.2) |
Clinically significant diabetes distress | 46.2 (48) |
Emotional burden | 2.5 (1.5) |
Total PHQ-9 score, mean (SD) | 5.9 (5.6) |
Screened positive | 21.2 (22) |
Somatic symptoms | 3.4 (2.9) |
Cognitive-affective symptoms | 2.5 (3.1) |
Total MADRS score, mean (SD) | 10.1 (9.0) |
Somatic symptoms | 3.5 (3.5) |
Cognitive-affective symptoms | 6.6 (6.3) |
Self-reported medication adherence | |
Percentage-based ratings, mean (SD) | 83.7 (21.9) |
Categorical ratings | |
Very poor | 0 (0) |
Poor | 6.7 (7) |
Fair | 8.7 (9) |
Good | 19.2 (20) |
Very good | 27.9 (29) |
Excellent | 37.5 (39) |
Data are presented as percentage (n) unless otherwise indicated.